Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Reubi

Showing results (171-180 of 210) with videos related to

Pageof 21
Sort By:
European Journal of Clinical Investigation|February 1, 1994
Somatostatin and the immune and haematopoetic system; a reviewP M van Hagen, E P Krenning, D J Kwekkeboom, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2010
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trialD Cordier, F Forrer, F Bruchertseifer, et al.
World Journal of Surgery|July 1, 1993
Use of isotope-labeled somatostatin analogs for visualization of islet cell tumorsC H van Eyck, H A Bruining, J C Reubi, et al.
Digestion|January 1, 1993
111In-octreotide scintigraphy in oncologyE P Krenning, D J Kwekkeboom, J C Reubi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristicsT W Huisman, H L Tanghe, J W Koper, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1992
Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitroT W de Bruin, D J Kwekkeboom, J W Van't Verlaat, et al.
Metabolism: Clinical and Experimental|September 1, 1992
111In-octreotide scintigraphy in oncologyE P Krenning, D J Kwekkeboom, J C Reubi, et al.
British Journal of Haematology|January 1, 1993
Somatostatin analogue scintigraphy of malignant lymphomasP M Vanhagen, E P Krenning, J C Reubi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapyM de Jong, W H Bakker, B F Bernard, et al.
Annals of Surgery|August 1, 1996
The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumorsC H van Eijck, S W Lamberts, L C Lemaire, et al.
Pageof 21

Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
European Journal of Clinical Investigation|February 1, 1994
Somatostatin and the immune and haematopoetic system; a reviewP M van Hagen, E P Krenning, D J Kwekkeboom, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2010
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trialD Cordier, F Forrer, F Bruchertseifer, et al.
World Journal of Surgery|July 1, 1993
Use of isotope-labeled somatostatin analogs for visualization of islet cell tumorsC H van Eyck, H A Bruining, J C Reubi, et al.
Digestion|January 1, 1993
111In-octreotide scintigraphy in oncologyE P Krenning, D J Kwekkeboom, J C Reubi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Progesterone, oestradiol, somatostatin and epidermal growth factor receptors on human meningiomas and their CT characteristicsT W Huisman, H L Tanghe, J W Koper, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1992
Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitroT W de Bruin, D J Kwekkeboom, J W Van't Verlaat, et al.
Metabolism: Clinical and Experimental|September 1, 1992
111In-octreotide scintigraphy in oncologyE P Krenning, D J Kwekkeboom, J C Reubi, et al.
British Journal of Haematology|January 1, 1993
Somatostatin analogue scintigraphy of malignant lymphomasP M Vanhagen, E P Krenning, J C Reubi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapyM de Jong, W H Bakker, B F Bernard, et al.
Annals of Surgery|August 1, 1996
The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumorsC H van Eijck, S W Lamberts, L C Lemaire, et al.
Pageof 21